News and Updates CMS Launches New Dementia Care Management Program Read More » July 31, 2023 New Drug Donanemab Shows Promise: Advancements in Early Alzheimer’s Treatment Read More » July 18, 2023 White Paper on cost implications of Leqembi and other anti-amyloid drugs for payers and ACOs and options for utilization management Read More » July 12, 2023 Introducing Leqembi: What You Need to Know About This Breakthrough in the Fight Against Alzheimer’s Disease Read More » July 10, 2023 Leqembi – Implications for Health Insurance Payers: A Comprehensive Analysis Read More » July 6, 2023 FAQ About Leqembi Read More » July 6, 2023 « Previous Page1 Page2 Page3 Page4 Page5 Next » Follow us Facebook Linkedin
New Drug Donanemab Shows Promise: Advancements in Early Alzheimer’s Treatment Read More » July 18, 2023
White Paper on cost implications of Leqembi and other anti-amyloid drugs for payers and ACOs and options for utilization management Read More » July 12, 2023
Introducing Leqembi: What You Need to Know About This Breakthrough in the Fight Against Alzheimer’s Disease Read More » July 10, 2023
Leqembi – Implications for Health Insurance Payers: A Comprehensive Analysis Read More » July 6, 2023
